Wishbone
Board
6 directors, 1 in day-to-day management, 1 auditor, no change since 2025INNODE NV
Chair and director, permanent representative François Blondel
chair appointed by deed of 26-11-2021
director since 29-10-2021
term until 30-09-2031
also on the board of 1 other company
listed in the 2025 annual accounts, filed on 07-07-2026
1 other company bankruptDirector, permanent representative Eric Rompen
current term since 29-10-2021
term until 30-09-2031
earlier chair, until 26-11-2021
earlier managing director, until 26-11-2021
listed in the 2025 annual accounts, filed on 07-07-2026
HALDYR BV
Director, permanent representative Simon Alexandre
current term since 29-10-2021
term until 30-09-2031
also on the board of 8 other companies
listed in the 2025 annual accounts, filed on 07-07-2026
Director
current term since 29-10-2021
term until 30-09-2031
also on the board of 3 other companies
listed in the 2025 annual accounts, filed on 07-07-2026
Director
since 03-06-2022
term until 30-09-2031
also on the board of 4 other companies
listed in the 2025 annual accounts, filed on 07-07-2026
WEBER Wiliam
Director
since 01-10-2025
term until 30-09-2031
listed in the 2025 annual accounts, filed on 07-07-2026
Statutory auditor
current term since 28-06-2024
term until 20-05-2027
listed in the 2025 annual accounts, filed on 07-07-2026
- Émilie Dory
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Two directors jointlydeed of 27-10-2025
Permanent representatives 3
Mandates through the years
19 names, the dashed line is todayHALDYR
Director
Director
ER Oral Surgery
Managing director and chair of the board
Managing director and chair of the board
THOMAS LIENARD
Director
Director
INNODE
Director, Chair
Director, Chair
OUSIA OPERATIONS
Director
Director
WEBER Wiliam
Director
Director
Émilie Dory
Director general and day-to-day manager
Director general and day-to-day manager
Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises
Statutory auditor
Statutory auditor
Galibier Life Sciences LTD
Managing director
Managing director
WEBER William
Director
Director
NOSHAQ PARTNERS
Director
Director
France Emmanuelle Lambert
Director
Director
Geoffrey LECLOUX
Director
Director
SPARAXIS
Director
Director
Eric Rompen Implantologie
Managing director and chair of the board
Managing director and chair of the board
Eric Rompen
Director
Director
Pierre L'HOEST
Director
Director
Simon Alexandre
Director
Director
Eric Henri Rompen
Director
Director
LeadershipBoardEarlierRest of the termmandate already running before its first mentionend not dated
Mandates as a list
- HALDYR
- Director, appointed by deed of 01-08-2018, still in office
- ER Oral Surgery
- Managing director and chair of the board, appointed by deed of 03-05-2019, still in office
- Managing director and chair of the board, appointed by deed of 03-05-2019, until 26-11-2021
- Managing director and chair of the board, appointed by deed of 03-05-2019, last mentioned in 2019
- THOMAS LIENARD
- Director, appointed by deed of 08-12-2020, still in office
- INNODE
- Director, from 29-10-2021 to date
- Chair, appointed by deed of 26-11-2021, still in office
- OUSIA OPERATIONS
- Director, from 03-06-2022 to date
- WEBER Wiliam
- Director, since before 31-12-2024
- Émilie Dory
- Director general and day-to-day manager, appointed by deed of 30-12-2025, still in office
- Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises
- Statutory auditor, appointed by deed of 01-08-2018, still in office
- Galibier Life Sciences LTD
- Daily management delegate, from 21-05-2021 to 21-06-2024
- Managing director, until 27-10-2025
- WEBER William
- Director, appointed by deed of 27-10-2025, no longer listed in the 2025 annual accounts
- NOSHAQ PARTNERS
- Director, appointed by deed of 01-08-2018, until 01-09-2022
- France Emmanuelle Lambert
- Director, appointed by deed of 24-12-2013, until 26-11-2021
- Geoffrey LECLOUX
- Director, appointed by deed of 24-12-2013, until 26-11-2021
- SPARAXIS
- Director, appointed by deed of 01-08-2018, until 26-11-2021
- Eric Rompen Implantologie
- Managing director and chair of the board, until 18-04-2019
- Eric Rompen
- Director, from before 19-05-2016, no longer listed in the 2025 annual accounts
- Pierre L'HOEST
- Director, from 19-12-2013, no longer listed in the 2025 annual accounts
- Simon Alexandre
- Director, from 19-12-2013, no longer listed in the 2025 annual accounts
- Eric Henri Rompen
- Director, from 19-12-2013, no longer listed in the 2025 annual accounts
Control
22.81%
This company
Wishbone
Equity €1.8m
Loss €1.2m in 2025
Capital
- Capital
- €2,149,578.04
- Shares
- 35,428 in the deed of 26-11-2021 and 3 later capital increases
- Contribution per share
- €60.67
- Equity per share
- €49.86 in 2025
- Source
- deed of 23-02-2026
Owners through the years
as the annual accounts name themOwners as a list
- EPIMEDE
- NOSHAQ VENTURE
- ORSA TECH
- ORSA FUND
- THE FAKTORY
- Wallonie Entreprendre
- SOCIETE REGIONALE D'INVESTISSEMENT DE WALLONIE
- BELINVEST
Source: lists of holdings in the owners' accounts
Articles of association
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 27-10-2025 (in French)
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “100% des actions par candidat de bonne foi non personne liée au sens article 1:20 CSA”deed of 26-11-2021 (in French)
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Thursday of May at 18:00deed of 27-10-2025 (in French)
Shareholders
6 ownersOwners 6
-
22.81%
- Equity €6.8m Loss of €1.9m in 2025 (loss of €484,171 in 2024) Checked score 4918.16%
- Equity €2.42bn Profit of €72.1m in 202211.46%
- Equity -€1.0m Loss of €343,640 in 2025 (profit of €85,088 in 2024) Checked score 5510.27%
- Equity €12.9m Profit of €3.0m in 2025 (profit of €3.1m in 2024) Checked score 932.9%
- Equity €17.3m Profit of €3.4m in 2025 (loss of €489,362 in 2024)Sourceaccounts ORSA FUND 20252.43%
Capital transactions
Shareholders according to the deeds
After the capital increase
deed of 28-06-2021 ↗
- S.A. EPIMEDE 1,661 shares · €1,051,894.69
- The Faktory 166 shares · €105,126.14
- S.R.I.W. 498 shares · €315,378.42
- FINANCIERE SPIN OFF 498 shares · €315,378.42
- Noshaq VENTURE (BE 0440.028.325) 1,247 shares · €789,712.63
After the capital increase
deed of 09-06-2015 ↗
- Belinvest 64 shares · €32,000
- Eric Rompen 68 shares · €34,000
- France Lambert 34 shares · €17,000
- Geoffrey LECLOUX 34 shares · €17,000
At incorporation
deed of 24-12-2013 ↗
- Eric Henri Rompen sole founder · 100% at incorporation
Capital over time
- 23-02-2026 Capital increase of €500,035.40 · to €2,149,578.04 · 2,362 new shares at €211.70 per share · in cash
- 27-10-2025 Capital increase of €1,500,106.20 · to €1,649,542.64 · 7,086 new shares at €211.70 per share · in cash
- 01-08-2023 Capital increase of €17,321.16 · to €166,757.60 · 2,698 new shares · in cash
- 26-11-2021 Capital increase of €19,247.16 · to €149,436.44 · 2,998 new shares at €633.29 per share, 12.9% of the 23,282 shares after the increase · in cash
- 28-06-2021 Capital increase of €26,129.40 · to €130,189.28 · 4,070 new shares at €6.42 per share, 20.1% of the 20,284 shares after the increase · “apport de créances”
- 01-08-2018 Capital increase of €11,767.86 · to €77,217.86 · 1,833 new shares · in kind
- 01-08-2018 Capital increase of €26,842.02 · to €104,059.88 · 4,181 new shares · in cash
- 09-06-2015 Capital increase of €2,200 · to €65,450 · 200 new shares, 3.4% of the 5,950 shares after the increase
Show 1 older capital entries
- 24-12-2013 Incorporation · €63,250 · 5,750 shares
The directors' other companies
1 current director with another company that went bankrupt, was dissolved or struck off1 other company of this director went bankrupt (2023).
- ALVALUX MEDICAL bankruptcy on 18-12-2023Official Gazettemandate until 2020
Source: Belgian Official Gazette (bankruptcies, judicial dissolutions, board mandates), FPS Economy (strike-offs) and the KBO register. A bankruptcy, dissolution or strike-off says nothing about the director's part in it.